263 related articles for article (PubMed ID: 32560258)
1. Multiple Roles of Transforming Growth Factor Beta in Amyotrophic Lateral Sclerosis.
Galbiati M; Crippa V; Rusmini P; Cristofani R; Messi E; Piccolella M; Tedesco B; Ferrari V; Casarotto E; Chierichetti M; Poletti A
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560258
[TBL] [Abstract][Full Text] [Related]
2. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
3. The Key Role of Astrocytes in Amyotrophic Lateral Sclerosis and Their Commitment to Glutamate Excitotoxicity.
Provenzano F; Torazza C; Bonifacino T; Bonanno G; Milanese M
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895110
[TBL] [Abstract][Full Text] [Related]
4. Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.
Wootz H; Weber E; Korhonen L; Lindholm D
Neuroscience; 2006 Dec; 143(2):419-30. PubMed ID: 16973300
[TBL] [Abstract][Full Text] [Related]
5. Excitotoxicity in ALS: Overstimulation, or overreaction?
King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2016 Jan; 275 Pt 1():162-71. PubMed ID: 26584004
[TBL] [Abstract][Full Text] [Related]
6. Excitotoxicity and amyotrophic lateral sclerosis.
Van Damme P; Dewil M; Robberecht W; Van Den Bosch L
Neurodegener Dis; 2005; 2(3-4):147-59. PubMed ID: 16909020
[TBL] [Abstract][Full Text] [Related]
7. Circuit Dysfunction in
Held A; Major P; Sahin A; Reenan RA; Lipscombe D; Wharton KA
J Neurosci; 2019 Mar; 39(12):2347-2364. PubMed ID: 30659087
[TBL] [Abstract][Full Text] [Related]
8. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G
J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-β signaling in motor neuron diseases.
Katsuno M; Adachi H; Banno H; Suzuki K; Tanaka F; Sobue G
Curr Mol Med; 2011 Feb; 11(1):48-56. PubMed ID: 21189118
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-β plasma levels and its role in amyotrophic lateral sclerosis.
Duque T; Gromicho M; Pronto-Laborinho AC; de Carvalho M
Med Hypotheses; 2020 Jun; 139():109632. PubMed ID: 32085981
[TBL] [Abstract][Full Text] [Related]
11. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
12. Membrane cholesterol depletion in cortical neurons highlights altered NMDA receptor functionality in a mouse model of amyotrophic lateral sclerosis.
Antonini A; Caioli S; Saba L; Vindigni G; Biocca S; Canu N; Zona C
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):509-519. PubMed ID: 29154925
[TBL] [Abstract][Full Text] [Related]
13. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms.
Wächter N; Storch A; Hermann A
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):431-41. PubMed ID: 26174443
[TBL] [Abstract][Full Text] [Related]
14. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
Heath PR; Shaw PJ
Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
16. DREAM-Dependent Activation of Astrocytes in Amyotrophic Lateral Sclerosis.
Larrodé P; Calvo AC; Moreno-Martínez L; de la Torre M; Moreno-García L; Molina N; Castiella T; Iñiguez C; Pascual LF; Mena FJM; Zaragoza P; Y Cajal SR; Osta R
Mol Neurobiol; 2018 Jan; 55(1):1-12. PubMed ID: 28840473
[TBL] [Abstract][Full Text] [Related]
17. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
[TBL] [Abstract][Full Text] [Related]
18. Differential involvement of vesicular and glial glutamate transporters around spinal α-motoneurons in the pathogenesis of SOD1
Ohgomori T; Yamasaki R; Takeuchi H; Kadomatsu K; Kira JI; Jinno S
Neuroscience; 2017 Jul; 356():114-124. PubMed ID: 28526579
[TBL] [Abstract][Full Text] [Related]
19. ALS skeletal muscle shows enhanced TGF-β signaling, fibrosis and induction of fibro/adipogenic progenitor markers.
Gonzalez D; Contreras O; Rebolledo DL; Espinoza JP; van Zundert B; Brandan E
PLoS One; 2017; 12(5):e0177649. PubMed ID: 28520806
[TBL] [Abstract][Full Text] [Related]
20. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
